Skip to main content
. 2018 Nov 13;9(89):35941–35961. doi: 10.18632/oncotarget.26310

Table 2. Growth response of tumoral pancreatic cell lines to gemcitabine (GEM).

Cell lines GEM IC50, nM
Mia-Paca2 150 ± 12
PANC1 200 ± 21
BxPC3 30 ± 8
Soj-6 12 ± 4
HPDE 20 ± 4
Capan-2* 46 ± 8

Cells were treated for 5 days in the absence or in the presence of different doses of GEM. Cell proliferation was assessed by MTT metabolism then IC50 determined. Values are the mean ± SD of 2 separate experiments. *, because Capan-2 cells display very low double time (94 hours), treatment with GEM was extended to 16 days.